{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,1,22]],"date-time":"2024-01-22T12:26:03Z","timestamp":1705926363912},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1097\/mbc.0b013e32836551b5","type":"journal-article","created":{"date-parts":[[2013,12,23]],"date-time":"2013-12-23T19:15:01Z","timestamp":1387826101000},"page":"46-51","source":"Crossref","is-referenced-by-count":5,"title":["Various laboratory protocols for measuring thromboxane A2 generation to detect the effectiveness of acetylsalicylic acid therapy"],"prefix":"10.1097","volume":"25","author":[{"given":"Marcin","family":"Rozalski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cezary","family":"Watala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacek","family":"Golanski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-9-20210203","doi-asserted-by":"crossref","first-page":"e89S","DOI":"10.1378\/chest.11-2293","article-title":"Antiplatelet drugs: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-based Clinical Practice Guidelines.","volume":"141","author":"Eikelboom","year":"2012","journal-title":"Chest"},{"key":"R2-9-20210203","doi-asserted-by":"crossref","first-page":"e637S","DOI":"10.1378\/chest.11-2306","article-title":"Primary and secondary prevention of cardiovascular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.","volume":"141","author":"Vandvik","year":"2012","journal-title":"Chest"},{"key":"R3-9-20210203","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1093\/eurheartj\/ehs092","article-title":"European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Developed with the special contribution of the European Association for Cardiovascular Prevention Rehabilitation (EACPR).","volume":"33","author":"Perk","year":"2012","journal-title":"Eur Heart J"},{"key":"R4-9-20210203","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1136\/hrt.2006.100891","article-title":"Residual platelet activity is increased in Clopidogrel- and ASA-treated patients with coronary stenting for acute coronary syndromes compared with stable coronary artery disease.","volume":"94","author":"Geisler","year":"2007","journal-title":"Heart"},{"key":"R5-9-20210203","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1001\/archinte.167.15.1593","article-title":"Association of laboratory-defined aspirin resistance with a higher risk of recurrent cardiovascular events: a systematic review and meta-analysis.","volume":"167","author":"Snoep","year":"2007","journal-title":"Arch Intern Med"},{"key":"R6-9-20210203","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ijcard.2007.12.010","article-title":"Residual platelet reactivity on aspirin therapy and recurrent cardiovascular events: a meta-analysis.","volume":"128","author":"Sofi","year":"2008","journal-title":"Int J Cardiol"},{"key":"R7-9-20210203","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1136\/bmj.39430.529549.BE","article-title":"Aspirin resistance and risk of cardiovascular morbidity: systematic review and meta-analysis.","volume":"336","author":"Krasopoulos","year":"2008","journal-title":"BMJ"},{"key":"R8-9-20210203","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1136\/hrt.2008.157321","article-title":"Aspirin resistance and its impact on cardiovascular morbidity and mortality: it is real, clinical relevant and should be measured.","volume":"95","author":"Brister","year":"2009","journal-title":"Heart"},{"key":"R9-9-20210203","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1002\/clc.20539","article-title":"The clinical significance of aspirin resistance in patients with chest pain.","volume":"33","author":"Aydinalp","year":"2010","journal-title":"Clin Cardiol"},{"key":"R10-9-20210203","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1111\/j.1365-2710.2009.01083.x","article-title":"Resistance to low-dose aspirin therapy among patients with acute coronary syndrome in relation to associated risk factors.","volume":"37","author":"Salama","year":"2012","journal-title":"J Clin Pharm Ther"},{"key":"R11-9-20210203","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.clineuro.2008.11.001","article-title":"Aspirin resistance determined with PFA-100 does not predict new thrombotic events in patients with stable ischemic cerebrovascular disease.","volume":"111","author":"Boncoraglio","year":"2009","journal-title":"Clin Neurol Neurosurg"},{"key":"R12-9-20210203","doi-asserted-by":"crossref","first-page":"I36","DOI":"10.1002\/clc.20371","article-title":"Antiplatelet therapy and platelet function testing.","volume":"31","author":"Braunwald","year":"2008","journal-title":"Clin Cardiol"},{"key":"R13-9-20210203","doi-asserted-by":"crossref","first-page":"e132","DOI":"10.1016\/j.thromres.2009.11.005","article-title":"The risk of false results in the assessment of platelet function in the absence of antiplatelet medication: comparison of the PFA-100, multiplate electrical impedance aggregometry and verify now assays.","volume":"125","author":"Can","year":"2010","journal-title":"Thromb Res"},{"key":"R14-9-20210203","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1751-553X.2008.01119.x","article-title":"Comparison of laboratory detection methods of aspirin resistance in coronary artery disease patients.","volume":"32","author":"Kim","year":"2010","journal-title":"Int J Lab Hematol"},{"key":"R15-9-20210203","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1093\/eurheartj\/ehn562","article-title":"Interindividual variability in the response to oral antiplatelet drugs: a position paper of the Working Group on antiplatelet drugs resistance appointed by the Section of Cardiovascular Interventions of the Polish Cardiac Society, endorsed by the Working Group on Thrombosis of the European Society of Cardiology.","volume":"30","author":"Kuliczkowski","year":"2009","journal-title":"Eur Heart J"},{"key":"R16-9-20210203","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1093\/eurheartj\/ehm226","article-title":"A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease.","volume":"28","author":"Lordkipanidze","year":"2007","journal-title":"Eur Heart J"},{"key":"R17-9-20210203","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1093\/eurheartj\/ehm505","article-title":"Comparison of different methods of measurement of aspirin resistance: using the appropriate statistic.","volume":"29","author":"Lotrionte","year":"2007","journal-title":"Eur Heart J"},{"key":"R18-9-20210203","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1136\/hrt.2008.150631","article-title":"Assessment of aspirin resistance varies on a temporal basis in patients with ischaemic heart disease.","volume":"95","author":"Muir","year":"2009","journal-title":"Heart"},{"key":"R19-9-20210203","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1309\/AJCPTE3K1SGAPOIZ","article-title":"Assessment of platelet function on whole blood by multiple electrode aggregometry in high-risk patients with coronary artery disease receiving antiplatelet therapy.","volume":"131","author":"Paniccia","year":"2009","journal-title":"Am J Clin Pathol"},{"key":"R20-9-20210203","first-page":"403","article-title":"Factors responsible for aspirin resistance: can we identify them Kardiol P","volume":"68","author":"Postula","year":"2010","journal-title":"ol"},{"key":"R21-9-20210203","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1751-553X.2012.01428.x","article-title":"Role of the laboratory in monitoring patients receiving dual antiplatelet therapy.","volume":"34","author":"Vidali","year":"2012","journal-title":"Int J Lab Hematol"},{"key":"R23-9-20210203","first-page":"154","article-title":"Use of flow cytomery to differentiate between activation and reactivity of blood platelets: methodological report.","volume":"5","author":"Watala","year":"2013","journal-title":"Med Sci Monit"},{"key":"R24-9-20210203","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0090-6980(90)90017-P","article-title":"Enzyme immunoassay measurement of the urinary metabolites of thromboxane A2 and prostacyclin.","volume":"40","author":"Lellouche","year":"1990","journal-title":"Prostaglandins"},{"key":"R25-9-20210203","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1160\/TH06-05-0242","article-title":"Multiple electrode aggregometry: a new device to measure platelet aggregation in whole blood.","volume":"96","author":"Toth","year":"2006","journal-title":"Thromb Haemost"},{"key":"R26-9-20210203","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/01.ftd.0000158084.84071.41","article-title":"Resistance to aspirin in patients after coronary artery bypass grafting is transient. Impact on the monitoring of aspirin antiplatelet therapy.","volume":"27","author":"Golanski","year":"2005","journal-title":"Therap Drug Monit"},{"key":"R27-9-20210203","doi-asserted-by":"crossref","first-page":"I10","DOI":"10.1002\/clc.20361","article-title":"Assessing the current role of platelet function testing.","volume":"31","author":"Braunwald","year":"2008","journal-title":"Clin Cardiol"},{"key":"R28-9-20210203","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.hlc.2009.11.002","article-title":"Serum thromboxane B2 compared to five other platelet function tests for the evaluation of aspirin effect in stable cardiovascular disease.","volume":"19","author":"Kidson-Gerber","year":"2010","journal-title":"Heart Lung Circ"},{"key":"R29-9-20210203","first-page":"187","article-title":"Radioimmunoassay of serum thromboxane B2: a simple method of assessing pharmacologic effects on platelet function.","volume":"6","author":"Patrono","year":"1980","journal-title":"Adv Prostaglandin Thromboxane Res"},{"key":"R30-9-20210203","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1160\/TH12-01-0026","article-title":"Increased platelet aggregation and serum thromboxane levels in aspirin-treated patients with prior myocardial infarction.","volume":"108","author":"Larsen","year":"2012","journal-title":"Thromb Haemost"},{"key":"R31-9-20210203","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1213\/ane.0b013e31818524c1","article-title":"Point-of-care whole blood impedance aggregometry versus classical light transmission aggregometry for detecting aspirin and clopidogrel: the results of a pilot study.","volume":"107","author":"Velik-Salchner","year":"2008","journal-title":"Anesth Analg"},{"key":"R32-9-20210203","doi-asserted-by":"crossref","first-page":"e489","DOI":"10.1161\/01.CIR.0000147228.29325.F9","article-title":"Platelet function testing in cardiovascular diseases.","volume":"110","author":"Michelson","year":"2004","journal-title":"Circulation"},{"key":"R33-9-20210203","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.jacc.2008.10.047","article-title":"Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: implications for aspirin resistance.","volume":"53","author":"Santilli","year":"2009","journal-title":"J Am Coll Cardiol"}],"container-title":["Blood Coagulation & Fibrinolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MBC.0b013e32836551b5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:32:05Z","timestamp":1620959525000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001721-201401000-00009"}},"subtitle":["a comparative study"],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/mbc.0b013e32836551b5","relation":{},"ISSN":["0957-5235"],"issn-type":[{"value":"0957-5235","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]}}}